Regression of cardiac hypertrophy in health and disease: mechanisms and therapeutic potential

TG Martin, MA Juarros, LA Leinwand - Nature Reviews Cardiology, 2023 - nature.com
Left ventricular hypertrophy is a leading risk factor for cardiovascular morbidity and mortality.
Although reverse ventricular remodelling was long thought to be irreversible, evidence from …

Mechanisms of physiological and pathological cardiac hypertrophy

M Nakamura, J Sadoshima - Nature Reviews Cardiology, 2018 - nature.com
Cardiomyocytes exit the cell cycle and become terminally differentiated soon after birth.
Therefore, in the adult heart, instead of an increase in cardiomyocyte number, individual …

Cardiac hypertrophy: mechanisms and therapeutic opportunities

S Gupta, B Das, S Sen - Antioxidants & redox signaling, 2007 - liebertpub.com
Cardiac hypertrophy and heart failure are major causes of morbidity and mortality in Western
societies. Many factors have been implicated in cardiac remodeling, including alterations in …

Hypertrophy of the heart: a new therapeutic target?

N Frey, HA Katus, EN Olson, JA Hill - Circulation, 2004 - Am Heart Assoc
Recent studies call into question the necessity of hypertrophic growth of the heart as a
“compensatory” response to hemodynamic stress. These findings, coupled with recent …

Decompensation of cardiac hypertrophy: cellular mechanisms and novel therapeutic targets

A Diwan, GW Dorn - Physiology, 2007 - journals.physiology.org
Cardiac hypertrophy leads to heart failure, and both conditions can ultimately prove lethal.
Here, traditional and novel mechanisms relating hypertrophy and heart failure are described …

[HTML][HTML] Cardiac hypertrophy: an introduction to molecular and cellular basis

M Samak, J Fatullayev, A Sabashnikov… - … science monitor basic …, 2016 - ncbi.nlm.nih.gov
Ventricular hypertrophy is an ominous escalation of hemodynamically stressful conditions
such as hypertension and valve disease. The pathophysiology of hypertrophy is complex …

Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies

BC Bernardo, KL Weeks, L Pretorius… - Pharmacology & …, 2010 - Elsevier
Cardiac hypertrophy can be defined as an increase in heart mass. Pathological cardiac
hypertrophy (heart growth that occurs in settings of disease, eg hypertension) is a key risk …

Cardiac hypertrophy: the good, the bad, and the ugly

N Frey, EN Olson - Annual review of physiology, 2003 - annualreviews.org
▪ Abstract Cardiac hypertrophy is the heart's response to a variety of extrinsic and intrinsic
stimuli that impose increased biomechanical stress. While hypertrophy can eventually …

Adaptive and maladaptive hypertrophic pathways: points of convergence and divergence

G Selvetella, E Hirsch, A Notte, G Tarone… - Cardiovascular …, 2004 - academic.oup.com
Myocardial hypertrophy is a response of cardiac muscle to altered conditions of
haemodynamic overload caused by a large number of physiological and pathological …

Molecular regulation of cardiac hypertrophy

SP Barry, SM Davidson, PA Townsend - The international journal of …, 2008 - Elsevier
Heart failure is one of the leading causes of mortality in the western world and encompasses
a wide spectrum of cardiac pathologies. When the heart experiences extended periods of …